Delphi Genetics significantly expands its capacities for cGMP plasmid DNA

Do you need plasmid DNA manufacturing slots, rapidly available, for your gene therapy programs?

You have come to the right place!

Delphi Genetics is currently significantly expanding its production capacities.

Three new flexible suites for single-use manufacturing of High Quality and cGMP plasmid DNA are currently being constructed. The suites are expected to be ready by early 2020, allowing the Belgian CDMO to further respond to its customers’ needs and welcome new partners for long-term relationships.

“The fast-growing gene therapy market and our customers’ requirements for a reliable and flexible manufacturing partner have convinced